Teva announces approvable status of Gabapentin capsules

Drug is the generic equivalent of Pfizer's Neurontin anticonvulsant
Publish date:

Teva Pharmaceutical Industries (Nasdaq:TEVA) said yesterday that the U.S. Food and Drug Administration has granted an "approvable" status for its ANDA for Gabapentin Capsules 100mg, 300mg and 400mg.

Gabapentin Capsules are the generic equivalent of Pfizer's anticonvulsant, Neurontin Capsules.

The brand product has annual sales of approximately $1.3 billion, Teva said.